Electrolyte Balance Effects of Sterofundin Versus Normal Saline in Diabetic Ketoacidosis

NCT ID: NCT06399510

Last Updated: 2024-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-01

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this prospective single centered randomized control trial is to compare the electrolyte balance effects between Sterofundin and Normal Saline in Diabetic Ketoacidosis patients. The main questions it aims to answer are:

i. Is there any difference in duration of bicarbonate (HCO3-) to reach equal or more than 15mmol/L from the initial blood taking in between Sterofundin and NS fluid use in DKA patients? ii. Is there any difference in the level of post-infusion serum sodium (Na+) between Sterofundin and NS fluid use in DKA patients? iii. Is there any difference in the level of post-infusion serum potassium (K+) between Sterofundin and NS fluid use in DKA patients?

Patients will be randomized in a 1:1 ratio to receive IV Sterofundin (intervention) or IV Normal Saline (standard care). The patient will have the respective fluid regime as the main fluid therapy during the first 24 hours of ICU stay. If patients were randomized to the control arm, the fluid regime for the first 24 hours in ICU will be normal saline. If patients were randomized to the interventional arm, the main fluid therapy during the first 24 hours of ICU stay will be Sterofundin.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Treatment Diabetic Ketoacidosis, Electrolyte Balance Effects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal Saline

If patients were randomized to the control arm, the fluid regime for the first 24 hours in ICU will be normal saline.

Group Type ACTIVE_COMPARATOR

Sterofundin fluid therapy

Intervention Type OTHER

Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.

Sterofundin

If patients were randomized to the interventional arm, the main fluid therapy during the first 24 hours of ICU stay will be Sterofundin.

Group Type EXPERIMENTAL

Sterofundin fluid therapy

Intervention Type OTHER

Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sterofundin fluid therapy

Sterofundin is known as balanced solution which has similar electrolytes content as per human plasma.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DKA.
* Aged ≄ 18 years old.
* Patients admitted to ICU \< 12 hours after initial fluid resuscitation from emergency department/ ward.

Exclusion Criteria

* End stage renal failure
* Heart failure
* Started treatment of sodium bicarbonate infusion prior to ICU admission
* Known allergy to Sterofundin
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universiti Sains Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohd Zulfakar Mazlan, MBBS

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universiti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shi Jie How

Role: CONTACT

+601151362495

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MOHD ZULFAKAR BIN MAZLAN, Master

Role: primary

+6097673000 ext. 6104

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USM/JEPeM/KK/23100751

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SODium BICarbonate for Metabolic Acidosis in the ICU
NCT05697770 ACTIVE_NOT_RECRUITING PHASE3
Fluid Administration in Ketoacidosis (DRINK)
NCT06541535 NOT_YET_RECRUITING PHASE4